Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Pregnant women confident in new blood test for Down's syndrome

22 September 2014

By Siobhan Chan

Appeared in BioNews 772

Women are confident in and value a new non-invasive prenatal test for Down's syndrome that is being trialled across a number of maternity clinics in the UK, a study reports.

Currently, at around 12 weeks, all pregnant women are offered routine Down's syndrome screening which estimates the risk of the baby being born with the condition. Women at high risk are offered invasive testing, where a needle is inserted into the abdomen, but this procedure carries a small risk of miscarriage. A new non-invasive maternal blood test is being trialled in the UK for medium- and high-risk women, which is safer and has detection rates of around 99 percent.

'The test allows women to have that extra reassurance in pregnancy if their results are negative. If the test is positive, it means they can make an informed choice about what to do next; further testing is required to verify the results, and the information may be valuable as it enables them to choose to either prepare for the birth of an affected child or terminate the pregnancy', said Dr Celine Lewis from University College London's Institute of Child Health, who led the study looking at women's views and experiences of this test and presented the research at the annual conference of the British Society for Genetic Medicine.

The team has so far surveyed more than 400 women and interviewed 70. The vast majority have been overwhelmingly positive about a new test that is safe, highly accurate and can be conducted early in pregnancy.

The research found that while most women found to be high risk following Down's syndrome screening opted for non-invasive prenatal testing, around ten percent opted for invasive testing. The research suggests one of the main reasons for this is because the results currently take seven to ten working days. Most invasive test results can be turned around in three working days.

'For some people, the most important thing is getting the results quickly, but for others it's more important not to put the pregnancy at risk, so they are willing to wait longer for a result from a safer test', said Dr Lewis.

Generally, women were pleased to have been offered the opportunity to have the non-invasive test, the researchers reported. 'People who'd had previous pregnancies said they felt a lot more reassured this time around because of the blood test result', said Dr Lewis.

The test is being trialled at eight antenatal clinics in the UK. The study is still ongoing, and the research will be completed by mid-2015.

Dr Celine Lewis was talking about her work prior to her talk 'Offering NIPT for Down syndrome in a National Health Service Clinical Setting - Experience of Patients in the UK' on Monday 22 September 2014 at the British Society for Genetic Medicine's annual conference, held at the Liverpool Arena and Convention Centre.

SOURCES & REFERENCES

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

07 November 2016 - by Dr Rachel Huddart 
A more accurate and safer prenatal test for Down's, Edward's and Patau's syndromes is to be offered by the NHS from 2018, it has been announced...
08 June 2015 - by Kirsty Oswald 
Researchers say that a non-invasive prenatal test for Down's syndrome is ready to be introduced into the NHS...
13 April 2015 - by Kirsty Oswald 
Research shows that a new prenatal blood test for Down's syndrome outperforms current methods of screening...
13 April 2015 - by Dr Ainsley Newson and Associate Professor Stacy Carter 
In March, Sequenom revealed that its MaterniT21 non-invasive prenatal test has detected potential cancer in some pregnant women. This is a good thing, right? Women in the prime of their lives receiving information that may catch a cancer early. But, we suggest, it is not this simple. ...
09 March 2015 - by Kirsty Oswald 
US company Sequenom has revealed that its prenatal blood test - MaterniT21 PLUS - has detected potential cancer in at least 40 expectant mothers since its launch three years ago...

11 August 2014 - by Dr Victoria Burchell 
Expectant mothers should be offered earlier screening for rare chromosomal conditions, the UK National Screening Committee (UK NSC) recommends...
10 March 2014 - by Dr Victoria Burchell 
A test using a simple blood sample from the expectant mother should soon be the primary screening method for Down's syndrome, according to a report from the Royal College of Obstetricians and Gynaecologists (RCOG)...
04 November 2013 - by María Victoria Rivas Llanos 
A new method for prenatal testing for Down's syndrome will be tried out at Great Ormond Street Hospital for Children (GOSH), London....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation